• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Biosckin

Biosckin

Molecular and Cell Therapies, S.A

  • Biosckin
  • Regenerative Medicine
    and Tissue Engineering
    • Cell therapies
    • Biomaterials
  • Products & Services
    • Covid-19 Products
    • Tests of Cyto and Biocompatibility
    • Cryopreservation of stem cells
    • Bonelike by Biosckin®
    • Flow cytometry
    • Growth factors from umbilical cord blood and dental pulp – CELLSECRET®
  • ID&I Nucleus
    • Projects
  • Contact us
  • English
  • Portuguese (Portugal)
Está aqui: Home / Regenerative Medicine and Tissue Engineering / Cell therapies and cell-based therapies

Cell therapies and cell-based therapies

The contribution of stem cells in modern medicine is of great importance, both for their broad use in basic research and for the opportunities they give us to develop new therapeutic strategies in clinical practice. Their characteristics make them valuable in a wide range of applications in biological and medical sciences.

A Cell Therapy is a medicinal product containing cells or cell products, and is typically injected into a patient. Examples include bone marrow transplants (also known as hematopoietic stem cell transplantation) and mesenchymal stem cell therapies.

Stem Cell Therapies are a type of cell therapy in which the cells used are either stem cells (as in the case of bone marrow or umbilical cord blood transplantation) or are derived from stem cells, as is this case with some stem cell therapies that are currently being investigated for their therapeutic potential in areas such as Regenerative Medicine.

Cell Therapy has been investigated in almost every degenerative disorder. Promising results from preclinical studies and clinical trials have already been described in several diseases, such as diabetes mellitus, chronic myeloid leukemia, cirrhosis, pulmonary fibrosis, Crohn’s disease, heart failure, and disorders of the nervous system, and the immunomodulatory effects of stem cells have found their utility in several conditions characterized by predominant inflammation.

Breaking News

PrintONorgans – Direct Biomanufacturing on Organs
Biosckin distinguida como PME Líder
Biosckin celebra parceria exclusiva com laboratório pioneiro na área de genética
Biosckin – laboratório Criovida tem protocolo científico com a Universidade do Porto desde 2007
Número crescente de aplicações clínicas das células estaminais do sangue do cordão umbilical
Biosckin, 10 anos de experiência e rigor
Grande potencial terapêutico das células estaminais do tecido do cordão umbilical em doenças do sistema imunológico
Biosckin no Projecto Inovação Portugal
Utilização de células estaminais do tecido do cordão umbilical na regeneração de lesões de nervo periférico
O avanço da utilização de células estaminais autólogas na área da medicina regenerativa
Uso do sangue do cordão umbilical em crianças com paralisia cerebral
Slider

Footer

Contacts

Biosckin, Molecular and Cell Therapies, S.A.

Tecmaia – Parque de Ciência e Tecnologia da Maia
Rua Engenheiro Frederico Ulrich, 2650
4470-605 – Moreira da Maia
Portugal

Telephone: (+351) 220 915 495
(+351) 220 915 498
Fax: (+351) 229 428 206

E-Mail: info@biosckin.com

  • LinkedIn

Sitemap

  • Biosckin
  • Regenerative Medicine and Tissue Engineering
  • Products & Services
  • ID&I Nucleus
  • News
  • Privacy Policy

Co-financing

Portuguese laboratory duly authorized by the Portuguese Authorities, the Directorate-General of Health

COPYRIGHT © 2021 BIOSCKIN · POWERED BY ACLSI